Rafat Abonour, MD, Indiana University School of Medicine, Indianapolis, IN, discusses some of the results of the Connect® MM study (NCT01081028), highlighting the need to better design clinical trials that represent patients in the real-world. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.